{
  "name" : "zero.sci-hub.se_6361_955fa5b0d6a916afca05da2d0579536b_kim2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Carbon nanomaterials as versatile platforms for theranostic applications",
    "authors" : [ "Mirae Kim", "Jinhyeong Jang", "Chaenyung Cha" ],
    "emails" : [ "(ccha@unist.ac.kr)" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Accepted Manuscript\nTitle: Carbon nanomaterials as versatile platforms for theranostic applications\nAuthors: Mirae Kim, Jinhyeong Jang, Chaenyung Cha\nPII: S1359-6446(17)30253-2 DOI: http://dx.doi.org/doi:10.1016/j.drudis.2017.05.004 Reference: DRUDIS 2022\nTo appear in:\nPlease cite this article as: Kim, Mirae, Jang, Jinhyeong, Cha, Chaenyung, Carbon nanomaterials as versatile platforms for theranostic applications.Drug Discovery Today http://dx.doi.org/10.1016/j.drudis.2017.05.004\nThis is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain."
    }, {
      "heading" : "Carbon nanomaterials as",
      "text" : "versatile platforms for theranostic applications"
    }, {
      "heading" : "Mirae Kim1,3, Jinhyeong Jang2,3, and Chaenyung Cha1",
      "text" : "1School of Materials Science and Engineering, Ulsan National Institute of Science and Technology, Ulsan 44919, Korea 2Department of Chemistry, School of Natural Science, Ulsan National Institute of Science and Technology, Ulsan 44919,"
    }, {
      "heading" : "Korea",
      "text" : "Corresponding author: Cha, C. (ccha@unist.ac.kr)\n3These authors contributed equally."
    }, {
      "heading" : "Highlights",
      "text" : " Theranostic approach is considered a future paradigm of nanomedicine\n Theranostic nanomedicine efficiently combines therapeutic and diagnostic functions\n Carbon nanomaterials have a diverse array of chemical and physical properties\n With this versatility, they are actively investigated as theranostic agents\nTeaser: With the emergence of ‘theranostic’ approaches to nanomedicine, carbon nanomaterials are leading the charge in theranostic nanomedicine with their unique blend of features.\nTheranostic nanomedicine, utilizing state-of-the-art, multifaceted nanomaterials and devices with therapeutic and diagnostic dual functions, has emerged as a highly attractive and promising new field of medicine. The theory behind the use of nanomaterials for theranostic applications is to impart multifunctionality by applying various engineering strategies to combine different modalities on a nanoscale. Carbon nanomaterials, which have been a subject of intense scientific research and industrial applications in recent years, have also found their way into theranostic nanomedicine owing to their innate multifunctionality. In this review, we outline recent research progress and trends in utilizing various types of carbon nanomaterial for theranostic applications.\nKeywords: theranostic; nanomedicine; carbon nanomaterials; carbon nanotube; graphene oxide; fullerene."
    }, {
      "heading" : "Introduction",
      "text" : "Nanomedicine can be broadly defined as the use of various nanoscale technologies in the field of medicine. The term is now more specifically used in reference to a new mode of pharmaceutics, namely the development and utilization of nanoscale materials with various physical and biochemical properties as novel therapeutic agents that could push the boundaries of traditional medicine [1]. Early attempts at nanomedicine were simply aimed at enhancing the therapeutic efficacy of existing drugs, such as conjugating hydrophilic polymers or encapsulating drugs in polymer-based nanoscale capsules (e.g., liposomes or micelles) as delivery vehicles that were designed to prolong the circulation life-time of the drug (Figure 1a) [2]. These nonspecific approaches were soon followed by, and often combined with, more specific ‘targeted’ approaches that introduced ligands with high binding affinity towards overexpressed or highly specific receptors at the targeted sites, thereby increasing the likelihood of local accumulation of the therapeutic agent [2]. More recently, advances in genomic analysis have opened the door to the\npossibility of ‘personalized nanomedicine’, whereby a patient’s genetic information is used to design a specific therapy [3].\nAlthough viewed by many as a promising future paradigm of medicine, therapeutic nanomedicine has not yet achieved its true clinical potential, because the current state of nanobiotechnology is not mature enough to overcome the cost:benefit ratio to replace traditional drug therapies, and requires greater technological depths to bring about a robust clinical outcome [4,5]. By contrast, diagnostic nanomedicines have enjoyed more clinical and commercial success. Unlike therapeutic agents that must be more stringently validated, diagnostic agents might only need to provide a supporting role for well-established diagnostic imaging tools, such as magnetic resonance imaging (MRI), X-ray computed tomography (CT), and positron emission tomography (PET) [6]. Therefore, functional nanomaterials that can respond to various electromagnetic radiations with proven biocompatibility and body clearance have been developed and have become common clinical practice. For example, superparamagnetic iron oxide and gadolinium nanoparticles (NPs) are used as T1 and T2 MRI contrast agents, respectively [7,8].\nThe continued technological advancements and recent trends in nanobiotechnology indicate that the direction of nanomedicine appears to be heading towards building ‘smart’ nanomaterials with both therapeutic and diagnostic functionalities [1,9–11]. This so-called ‘theranostic’ approach to nanomedicine is only natural from an engineering perspective to maximize the efficiency by combining the best of both worlds. According to several accounts, the term ‘theranostic’ was first coined in 1998 by John Funkhouser, then CEO of PharmaNetics, Inc., to describe a diagnostic test that directly accompanies a specific therapy [11]. However, the term is now more generally used to describe nanomaterials or technologies that allow for simultaneous diagnosis and therapy. Most strategies to create theranostic nanomaterials involve labelling drug-loaded nanocarriers with optical probes, such as radioactive (e.g., 125I, 111In, 18F, and 15O) and fluorescent (e.g., green fluorescent protein, Cy5, indocyanine, and quantum dot) moieties to monitor their biodistribution [12]. More recently, gold NPs have received increasing interest as a promising theranostic agent because of their surface plasmonic effects that allow for fluorescence imaging [e.g., fluorescence tomography and near-infrared (NIR) fluorescence imaging] and photothermal therapies [13]."
    }, {
      "heading" : "Carbon nanomaterials for theranostics",
      "text" : "Beyond the field of medicine, carbon nanomaterials, such as carbon nanotubes (CNT) and graphene, have driven the nanotechnology research efforts in recent years, leading to several successful commercializations (Figure 1) [14–16]. Their multifunctional nature (e.g., high mechanical strength, electrical conductivity, optical properties, and tunable dimensions), resulting from their 2D array of sp2 carbons, is ideally suited for various industrial applications, especially in electronics, photonics, and composite materials. In addition, several efficient methods have been developed to derive various carbon nanomaterials from graphite, which is abundant in nature, making them especially attractive in terms of their economic value [14–16].\nAlthough they share several physical properties, each type of carbon nanomaterial has its characteristic features. For example, sp2-carbon based nanomaterials, such as graphene and CNT, have an extensive conjugated π-electron system, which imparts extremely high mechanical strength, electrical and thermal conductivity, and optical properties (e.g., NIR fluorescence and Raman scattering) [14–16]. However, these properties can be finetuned by controlling their physical dimensions (i.e., size and shape) with reaction conditions (e.g., reaction temperature and duration, substrate type, catalyst, and lithography-based patterning) and chemical doping schemes [17]. By contrast, nanodiamonds (NDs) comprise mostly tetrahedral clusters of sp3-carbon and demonstrate photoluminescence as well as fluorescence, making them well suited for imaging purposes, although they lacks electrical and thermal conductivities [18].\nGiven these interesting and useful properties of carbon nanomaterials, there are extensive research efforts investigating their use for various biomedical engineering applications [19–22]. For theranostic nanomedicine, carbon nanomaterials are deemed especially attractive for several reasons. First, they have inherent optical properties that are well suited for diagnostic imaging purposes, eliminating the need for further modification (although one might elect to add other imaging functionalities) [19]. In particular, the light absorbance in the NIR region induces photothermal and photodynamic effects, which have been shown to be effective for cancer therapy [20,21]. In addition, NIR has greater penetration depth, and lower excitation scattering and autofluorescence than conventional visible range fluorescence, making it ideal for in vivo imaging. Second, sp2-carbon nanomaterials have a large surface area onto which drug molecules can be loaded via physical adsorption or covalent conjugation for drug delivery applications. Third, there are several chemical modification strategies that can be used to conjugate various moieties to generate a diverse array of functions [22].\nBelow, we provide a comprehensive overview of recent advances in engineering various carbon nanomaterials [e.g., CNTs, graphene, buckminsterfullerene (C60), NDs, and carbon dots] for theranostic applications. The unique aspects of each type of carbon nanomaterial as well as the common physicochemical properties shared among different carbon nanomaterials are presented, with particular emphasis on their relations to theranostic potential. Several notable examples are also highlighted and discussed."
    }, {
      "heading" : "Carbon nanotubes",
      "text" : "Although carbon nanomaterials as a collective terminology has garnered wide popularity in recent years, they have a history dating back to 1950s. However, the first true systematic investigation of carbon nanomaterials was done by Sumio Iijima in 1991, when he synthesized and characterized the structure of CNTs [14,15]. Since then, CNTs have become one of the most studied nanomaterials to date, mostly for electronics and as high-strength composite\nmaterials. CNTs have a hollow cylindrical sp2-carbon structure with controllable dimensions, such as length, diameter, and the number of walls. For example, Cheung and co-workers demonstrated that the diameter of CNTs could be controlled by varying the size of the catalytic iron nanoclusters [23]. Choi and co-workers also controlled the diameter by adjusting the grain size of a thin layer of nickel on a silicon substrate grain [24]. Baliyan and coworkers showed that the number of walls in CNTs could be controlled by changing the rate of addition of the carbon source, methane, during CNT synthesis [25]. In nanomedicine, CNTs are actively explored in areas such as drug delivery and imaging, often simultaneously in a theranostic approach because of their aforementioned multifunctional properties [22].\nFor diagnostic imaging, the inherent NIR fluorescence and Raman scattering effects are generally utilized, sometimes coupling with other imaging agents, such as iron oxide NPs for MRI and gold NPs for surface plasmon resonance [26]. For therapeutic effects, CNTs are often loaded with drugs either within the hollow inner channel or on the wall surface via hydrophobic interaction. Alternatively, drug molecules are conjugated onto the wall surface for more robust and controlled delivery (i.e., physical drug loading can lead to premature release) [27]. The therapeutic effect can also be elicited by photothermal effects, in which the absorbance in the NIR region by locally accumulated CNTs leads to an elevated temperature that is high enough to kill tumor tissue as a cancer therapy. For example, Kam and co-workers developed single-walled CNTs (SWNTs) labeled with a single-stranded DNA that facilitated internalization by breast cancer cells (HeLa) [28]. They further engineered SWNTs by conjugating poly(ethylene glycol) (PEG), which helped stabilize SWNTS in the aqueous environment, and folic acid, which is a targeting ligand for HeLa cells. The excitation of SWNTs localized in HeLa cells in the NIR region (808 nm) resulted in an elevated temperature leading to significant cell death, thus demonstrating the possible use of SWNTs as a photothermic agent for cancer therapy. Wang and co-workers similarly developed SWNTs modified with noble metals (gold or silver), which significantly enhanced the surface-enhanced Raman scattering (SERS) effect induced by NIR laser excitation (Figure 2) [29]. The presence of gold on SWNTs further enhanced the photothermal effects because of surface plasmon resonance. In another study, Liu and co-workers further explored the versatility of SWNT-based theranostic agents by demonstrating the synergistic cancer therapeutic effects of the photothermally triggered release of doxorubicin, an anticancer drug [30].\nAlthough the fluorescent optical imaging conferred by CNTs is a valuable diagnostic tool, it often has limited resolution with tissue depth, even in the NIR range. Photoacoustic imaging, most notably ultrasound, could overcome those limitations by providing more accurate imaging analysis at greater depth. In addition, there is a greater economic value in using photoacoustic imaging for diagnosis, because the ultrasound equipment is more affordable and widespread than optical imaging-based tools, such as MRI and CT. For theranostic nanomedicine, photoacoustic imaging has not been extensively explored because the microbubbles, the most common type of nanomaterial used as contrast agents, are not useful as therapeutic agents. However, in recent studies of CNTbased theranostics, several research groups have demonstrated the innate photoacoustic effect of CNT. For example, De La Zerda and co-workers used RGD peptide-conjugated SWNTs as a tumor-targeting photoacoustic contrast agent [31]. Recent work by Wang and co-workers similarly reported that a hyaluronic acid-CNT complex was able to target CD44-overexpressed tumor tissue in vivo, and demonstrated the enhanced contrast for ultrasound imaging [32]."
    }, {
      "heading" : "Graphene and graphene oxide",
      "text" : "It may seem counterintuitive that graphene is the latest carbon nanomaterial that has received worldwide attention, given that the existence of graphene, which is the building block for natural graphite as well as other carbon nanomaterials, such as CNTs and C60, has been well established for some time. However, there were issues related to isolating single graphene layers from graphite for further scientific inquiry, until Geim and Novoselov developed a simple ‘exfoliation’ method [33]. Since this seminal work, graphene research, both scientific and industrial, has been at the forefront of nanotechnology research over the past decade. Inevitably, the popularity of graphene has also spread to biomedical fields, leading to a significant increase in the number of publications in recent years [20,34]. In theranostic nanomedicine, graphene is generally used in the same fashion as CNTs, because they have the same chemical composition (sp2-carbon) leading to similar physical properties. For example, Gollavelli and co-workers developed a dual-imaging magnetic and fluorescent graphene (MFG) by labeling graphene with iron and fluorescein [35]. The MFG was further modified with a photosensitizer, silicon 2,3- naphthanlocyanine bis(trihexylsilyloxide), which enhanced the photothermic and photodynamic effects for cancer therapy.\nIt is often desirable that nanomaterials used in theranostic applications be hydrophilic so that they are easily dispersed in aqueous environments. Given that pure graphene is inherently hydrophobic, it is often modified with hydrophilic moieties (e.g., functional groups, oligomers, and polymers). For this reason, graphene oxide (GO) is often preferred over pure graphene in various biomedical applications, including theranostics, especially when electrical conductivity is not a critical factor. In addition, because GO is not only dispersible in aqueous solutions because of its hydrophilic functional groups, those groups could be further chemically modified to attach various modalities. It also has an added advantage of efficient mass production from graphite via acidic oxidation (e.g., Hummers’ method). Other carbon nanomaterials are not generally oxidized because, unlike graphene, which is a 2D planar structure, they have well-defined 3D structures that could be damaged by harmful oxidizing conditions. In addition, the purpose of graphene oxidation is not only to impart aqueous dispersibility, but also to attain the\nmass production of GO from natural graphite. However, other carbon nanomaterials are synthesized in more defined conditions and in lower quantities. Therefore, their aqueous dispersibility is usually accomplished by introducing hydrophilic molecules under mild reaction conditions.\nWang and co-workers developed a multimodal GO-based theranostic agent by covalently conjugating lanthanidebased upconversion nanoparticles (UCNP) as a photosensitizer for NIR fluorescence imaging, and photodynamic/photothermal therapy [36]. The presence of UCNPs significantly enhanced the optical properties of GO. In addition, GO was conjugated with PEG, which enhanced the hydrophilic stability and acted as a linker for the UCNP. Another advantage of using GO over graphene is that much of the conjugated system of graphene can be easily restored [i.e., reduced graphene oxide (rGO)] by chemical reduction of GO. Therefore, many researchers combine the mass producibility and chemical processibility of GO with GO reduction into rGO for enhanced optical properties [37].\nThe increasing popularity of ‘wearable’ electronic devices has also significantly elevated the popularity of graphene, because it allows for the facile fabrication of flexible sheet-like conductive materials owing to its 2D structure [38]. The graphene-based flexible electronics have great potential as point-of-care theranostic medical devices, in which an electronic biosensor and a drug delivery device are assembled on a patch-type graphene-based flexible substrate for topical applications. In recent research, Lee and co-workers developed a graphene-based flexible electronic device equipped with a glucose sensor and a drug-eluting microneedle array for hyperglycemia monitoring and treatment (Figure 3) [39]. They successfully demonstrated that the electrochemical sensor array on a highly flexible graphene substrate could provide the accurate detection of the glucose level. The signals obtained from the sensor, in turn, were transmitted via wireless communication to a microneedle array unit from which the drug was released by thermal actuation."
    }, {
      "heading" : "Buckminsterfullerene",
      "text" : "Although graphene and CNT have dominated the nanomedicine research, other types of carbon nanomaterial have also been explored as theranostic agents. C60, a.k.a. ‘bucky-ball’, has a unique and unusual truncated icosahedron structure comprising 60 carbons (i.e., a spherical closed-cage resembling a soccer ball). Although its popularity has been over taken by that of CNT and graphene in recent years, it was the first carbon-based nanomaterial to be discovered (in 1985), and extensively investigated for its chemical and physical properties [16,40]. Being part of the fullerene family, the physical nature of C60 is similar to that of CNTs and graphene, and, therefore, its theranostic applications have also largely focused on utilizing fluorescence-based imaging and photodynamic/photothermal therapy [41]. Given its relatively small size (diameter of 0.7 nm), C60 is often incorporated into other nanostructures as a functional modality. For example, Liu and co-workers conjugated C60 on UCNP, along with folic acid as a targeting ligand, for NIR fluorescence and photodynamic therapy (Figure 4A) [42]. Similarly, Li and co-workers developed a C60-dendrimer supramolecular nanocomposite in which hydrophobic C60 was fused into the core of the hydrophilic dendrimer (Figure 4B) [43].\nAlthough generally stable, the most notable difference of C60 compared with other carbon nanomaterials is its greater susceptibility to chemical reactions, particularly addition [44]. It stems from the fact that C60 is not a total conjugated system; the double bonds on hexagons (i.e., [6,6] bonds) are considered as cyclohexatriene and those on pentagons (i.e., [5,6] bonds) as radialene, with the [6,6] bond being shorter than the [5,6] bond (Figure 4C). The chemical reactivity of C60 is further increased by the increased ring strain of a spherical structure. For theranostic applications, C60 is often covalently conjugated with a biopolymer, such as hyaluronic acid, and PEG for aqueous solubility and biocompatibility (Figure 4D) [45]. In addition, these C60-polymer conjugate could be further engineered to fabricate theranostic vesicles."
    }, {
      "heading" : "Nanodiamonds and carbon dots",
      "text" : "Aside from more commonly explored sp2-carbon-based CNT, graphene and C60, more recent investigation has shed the light on other types of carbon nanomaterials. NDs are one such carbon nanomaterial. NDs are naturally occurring but more commonly obtained from graphite by detonation, and have the same chemical composition and optical properties as the bulk diamond (i.e., tetrahedral sp3-carbon clusters with photoluminescence and fluorescence) [18,46] The presence of sp2-carbons on their surface allows for chemical modifications to attach theranostic modalities. For example, Zhang and co-workers developed a ND-based theranostic nanomaterial by linking an antibody to the epithelial growth factor receptor, which is overexpressed in many solid tumors, and an anticancer drug, paclitaxel, for targeted drug delivery and imaging [47].\nCarbon dots (a.k.a. carbon nanodots and carbon quantum dots) are the latest class of carbon-based nanomaterial that have received much attention since they were first discovered in 2004 [48]. Carbon dots can be prepared ‘topdown’ from other carbon nanomaterials, or ‘bottom-up’ by hydrothermal or microwave treatment (‘carbonization’) of smaller carbon sources, such as carbohydrates and citric acid. Although their exact physical nature is still unknown, as the name indicates, they have tunable fluorescent and luminescent properties similar to semiconductor-based quantum dots but with lower toxicity. Therefore, the carbon dots are explored in theranostics in much the same way as other carbon nanomaterials. For example, Ge and co-workers developed red-fluorescent carbon dots synthesized via carbonization of poly(thiophene phenylpropionic acid), a conjugated conducting polymer, for fluorescent imaging and photoacoustic/photothermal therapy [49].\nConcluding remarks and future perspectives\nNot long ago, nanotechnology was a concept that was highly attractive and promising, but seemed out of reach. With remarkable scientific and engineering endeavors resulting in novel nanoscale materials and fabrication techniques, it is slowly becoming a reality in many facets of our lives. The importance and impact of carbon-based nanomaterials on advancing nanotechnology cannot be overstated. Their interesting and highly useful physical and chemical properties, as well as their structural diversity, are ideally suited for this purpose. Given that many consider biology and medicine as the latest frontier in science and technology, it is only natural that the principles of nanotechnology are being adopted to further advance these fields, hence entering the new era of ‘nanobiotechnology’. To tackle the complexities associated with biomedical applications, it is desirable to engineer multifunctional nanomaterials. Therefore, the versatile nature of carbon nanomaterials is ideally suited and expected to have a major role in this endeavor.\nThere have been remarkable advances in theranostic applications of carbon nanomaterials, as outlined in here, and this upward trajectory is expected to continue. However, toxicological evaluation of carbon nanomaterials should be a major research focus going forward if carbon-based theranostic nanomedicine is to have real commercial value. Similar to any other therapeutics, the biocompatibility of carbon nanomaterials must be fully established for eventual clinical translation. Given the relative infancy of CNTs in theranostic applications and inadequate preclinical studies, they have not been investigated in clinical settings so far, and toxicity evaluations have been mostly done in vitro using various cell types [50]. More recently, there have been several research efforts to evaluate the in vivo toxicity of carbon nanomaterials, especially CNTs, which are the most commonly utilized and, therefore, deemed closer to commercialization [51]. However, these efforts have been sporadic at best, with variable results.\nIt is somewhat broadly accepted that there is an elevated level of cytotoxicity involved with carbon nanomaterials largely because of their hydrophobicity causing unwanted adsorption of biological species as well as cellular uptake and accumulation [52,53]. This is somewhat controversial given that there are many published research results demonstrating otherwise, or that it could be at least circumvented by incorporating biocompatible moieties [54]. This highly variable outcome likely stems from the diversity of the carbon nanomaterial itself, in which the cytotoxic effects have been shown to depend on the physical properties (e.g., size and shape), fabrication methods, and surface functionalization [55].\nIn light of these studies, it is clear that the standardization of carbon materials, both the fabrication method and properties, must be a focus going forward to properly categorize and characterize these materials, which is a crucial step for clinical translation. Needless to say, more systematic and expansive toxicological and pharmacokinetic investigations (both systemic and local) of various types of carbon nanomaterial are expected to continue and become a more important topic in the field of biomedicine. Furthermore, with the possibility of the release of carbon nanomaterials into the environment, bioaccumulation and ecotoxicity studies also must be done in the near future.\nAcknowledgments This work was supported by the 2016 Research Fund (1.160094.01) of UNIST (Ulsan National Institute of Science and Technology), Civil-Military Technology Cooperation Program (15-CM-SS-03), and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A02037666)\nReferences\n1 Farokhzad, O.C. and Langer, R. (2006) Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliv. Rev. 58,\n1456–1459\n2 Elsabahy, M. and Wooley, K.L. (2012) Design of polymeric nanoparticles for biomedical delivery applications. Chem. Soc. Rev. 41, 2545–\n2561\n3 Nicolini, C. et al. (2012) Nanoproteomics enabling personalized nanomedicine. Adv. Drug Deliv. Rev. 64, 1522–1531 4 Moghimi, S.M. et al. (2005) Nanomedicine: current status and future prospects. FASEB J. 19, 311–330 5 Wagner, V. et al. (2006) The emerging nanomedicine landscape. Nat. Biotechnol. 24, 1211–1217 6 Hahn, M.A. et al. (2011) Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal. Bioanal.\nChem. 399, 3–27\n7 Wang, Y-X.J. (2011) Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant. Imaging Med.\nSurg. 1, 35–40\n8 Caravan, P. et al. (1999) Gadolinium(iii) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99, 2293–2352 9 Xie, J. et al. (2010) Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 62, 1064–1079 10 Lammers, T. et al. (2011) Theranostic nanomedicine. Acc. Chem. Res. 44, 1029–1038 11 Adiga, S. and Adiga, U.S. (2014) Theranostics: past, present and future. Int. J. Pharm. Bio. Sci. 4, 50–55 12 Dufort, S. et al. (2010) Optical small animal imaging in the drug discovery process. BBA-Biomembranes 1798, 2266–2273 13 Boisselier, E. and Astruc, D. (2009) Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem.\nSoc. Rev. 38, 1759–1782\n14 Gogotsi, Y. and Presser, V. (2013) Carbon Nanomaterials, CRC Press 15 Krüger, A. (2010) Carbon Materials and Nanotechnology, Wiley-VCH 16 Pierson, H.O. (1993) Handbook of Carbon, Graphite, Diamond, and Fullerenes: Properties, Processing, and Applications, Noyes Publications 17 Zhang, M. and Li, J. (2009) Carbon nanotube in different shapes. Materials Today 12, 12–18 18 Mochalin, V.N. et al. (2012) The properties and applications of nanodiamonds. Nat. Nanotechnol. 7, 11–23 19 Cha, C. et al. (2013) Carbon-based nanomaterials: multifunctional materials for biomedical engineering. ACS Nano 7, 2891–2897 20 Yang, K. et al. (2013) Nano-graphene in biomedicine: theranostic applications. Chem. Soc. Rev. 42, 530–547 21 Zhang, Y. et al. (2010) Functionalized carbon nanotubes for potential medicinal applications. Drug Discov. Today 15, 428–435 22 Vardharajula, S. et al. (2012) Functionalized carbon nanotubes: biomedical applications. Int. J. Nanomedicine 7, 5361–5374 23 Cheung, C.L. et al. (2002) Diameter-controlled synthesis of carbon nanotubes. J. Phys. Chem. B 106, 2429–2433\n24 Choi, Y.C. et al. (2000) Controlling the diameter, growth rate, and density of vertically aligned carbon nanotubes synthesized by microwave\nplasma-enhanced chemical vapor deposition. Appl. Phys. Lett. 76, 2367–2369\n25 Baliyan, A. et al. (2013) Precise control of the number of walls of carbon nanotubes of a uniform internal diameter. J. Phys. Chem. C 117,\n683–686\n26 Gong, H. et al. (2013) Carbon nanotubes for biomedical imaging: the recent advances. Adv. Drug Deliv. Rev. 65, 1951–1963 27 Wong, B.S. et al. (2013) Carbon nanotubes for delivery of small molecule drugs. Adv. Drug Deliv. Rev. 65, 1964–2015 28 Kam, N.W.S. et al. (2005) Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell\ndestruction. Proc. Natl. Acad. Sci. U.S.A. 102, 11600–11605\n29 Wang, X. et al. (2012) Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging\nand photothermal therapy. J. Am. Chem. Soc. 134, 7414–7422\n30 Liu, J. et al. (2015) Mesoporous silica coated single-walled carbon nanotubes as a multifunctional light-responsive platform for cancer\ncombination therapy. Adv. Funct. Mater. 25, 384–392\n31 De La Zerda, A. et al. (2008) Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat. Nanotechnol. 3, 557–562 32 Wang, G. et al. (2016) Nanotubes-embedded indocyanine green-hyaluronic acid nanoparticles for photoacoustic-imaging-guided\nphototherapy. ACS Appl. Mater. Interfaces 8, 5608–5617\n33 Geim, A.K. and Novoselov, K.S. (2007) The rise of graphene. Nat. Mater. 6, 183–191 34 Chung, C. et al. (2013) Biomedical applications of graphene and graphene oxide. Acc. Chem. Res. 46, 2211–2224 35 Gollavelli, G. and Ling, Y-C. (2014) Magnetic and fluorescent graphene for dual modal imaging and single light induced photothermal and\nphotodynamic therapy of cancer cells. Biomaterials 35, 4499–4507\n36 Wang, Y. et al. (2013) Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and\nphotothermal/photodynamic cancer therapy. Biomaterials 34, 7715–7724\n37 Robinson, J.T. et al. (2011) Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J. Am. Chem.\nSoc. 133, 6825–6831\n38 Gomez De Arco, L. et al. (2010) Continuous, highly flexible, and transparent graphene films by chemical vapor deposition for organic\nphotovoltaics. ACS Nano 4, 2865–2873\n39 Lee, H. et al. (2016) A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapy.\nNat. Nanotechnol. 11, 566–572\n40 Shinar, J. et al., eds (2000) Optical and Electronic Properties of Fullerenes and Fullerene-Based Materials, Marcel Dekker 41 Partha, R. and Conyers, J.L. (2009) Biomedical applications of functionalized fullerene-based nanomaterials. Int. J. Nanomedicine 4, 261–\n275\n42 Liu, X. et al. (2013) Separately doped upconversion-C60 nanoplatform for NIR imaging-guided photodynamic therapy of cancer cells. Chem.\nComm. 49, 3224–3226\n43 Li, X. et al. (2015) Facile construction of well-defined fullerene-dendrimer supramolecular nanocomposites for bioapplications. Chem.\nComm. 51, 2851–2854\n44 Geckeler, K.E. and Samal, S. (1999) Syntheses and properties of macromolecular fullerenes, a review. Polym. Int. 48, 743–757 45 Kwag, D.S. et al. (2013) Hyaluronated fullerenes with photoluminescent and antitumoral activity. Chem. Comm. 49, 282–284 46 Zhu, Y. et al. (2012) The biocompatibility of nanodiamonds and their application in drug delivery systems. Theranostics 2, 302–312 47 Zhang, X-Q. et al. (2011) Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic\nefficacy. Adv. Mater. 23, 4770–4775\n48 Baker, S.N. and Baker, G.A. (2010) Luminescent carbon nanodots: Emergent nanolights. Angew. Chem. Int. Ed. 49, 6726–6744 49 Ge, J. et al. (2015) Red-emissive carbon dots for fluorescent, photoacoustic, and thermal theranostics in living mice. Adv. Mater. 27, 4169–\n4177\n50 Jia, G. et al. (2005) Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ. Sci. Technol.\n39, 1378–1383\n51 Fraczek, A. et al. (2008) Comparative in vivo biocompatibility study of single- and multi-wall carbon nanotubes. Acta Biomater. 4, 1593–\n1602\n52 Firme Iii, C.P. and Bandaru, P.R. (2010) Toxicity issues in the application of carbon nanotubes to biological systems. Nanomed.\nNanotechnol. Biol. Med. 6, 245–256\n53 Lacerda, L. et al. (2006) Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv. Drug. Deliver. Rev. 58, 1460–1470 54 Liu, Z. et al. (2008) Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by\nRaman spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 105, 1410–1415\n55 Madani, S.Y. et al. (2013) A concise review of carbon nanotube’s toxicology. Nano Rev. 4, 21521"
    } ],
    "references" : [ {
      "title" : "Nanomedicine: developing smarter therapeutic and diagnostic modalities",
      "author" : [ "O.C. Farokhzad", "R. Langer" ],
      "venue" : "Adv. Drug Deliv. Rev",
      "citeRegEx" : "Farokhzad and Langer,? \\Q2006\\E",
      "shortCiteRegEx" : "Farokhzad and Langer",
      "year" : 2006
    }, {
      "title" : "Design of polymeric nanoparticles for biomedical delivery applications",
      "author" : [ "M. Elsabahy", "K.L. Wooley" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "Elsabahy and Wooley,? \\Q2012\\E",
      "shortCiteRegEx" : "Elsabahy and Wooley",
      "year" : 2012
    }, {
      "title" : "Nanoproteomics enabling personalized nanomedicine",
      "author" : [ "C Nicolini" ],
      "venue" : "Adv. Drug Deliv. Rev",
      "citeRegEx" : "Nicolini,? \\Q2012\\E",
      "shortCiteRegEx" : "Nicolini",
      "year" : 2012
    }, {
      "title" : "Nanomedicine: current status and future prospects",
      "author" : [ "Moghimi", "S.M" ],
      "venue" : "FASEB J",
      "citeRegEx" : "Moghimi and S.M,? \\Q2005\\E",
      "shortCiteRegEx" : "Moghimi and S.M",
      "year" : 2005
    }, {
      "title" : "The emerging nanomedicine landscape",
      "author" : [ "V Wagner" ],
      "venue" : "Nat. Biotechnol",
      "citeRegEx" : "Wagner,? \\Q2006\\E",
      "shortCiteRegEx" : "Wagner",
      "year" : 2006
    }, {
      "title" : "Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives",
      "author" : [ "Hahn", "M.A" ],
      "venue" : null,
      "citeRegEx" : "Hahn and M.A,? \\Q2011\\E",
      "shortCiteRegEx" : "Hahn and M.A",
      "year" : 2011
    }, {
      "title" : "Gadolinium(iii) chelates as MRI contrast agents: structure, dynamics, and applications",
      "author" : [ "P Caravan" ],
      "venue" : "Chem. Rev",
      "citeRegEx" : "Caravan,? \\Q1999\\E",
      "shortCiteRegEx" : "Caravan",
      "year" : 1999
    }, {
      "title" : "Nanoparticle-based theranostic agents",
      "author" : [ "J Xie" ],
      "venue" : "Adv. Drug Deliv. Rev",
      "citeRegEx" : "Xie,? \\Q2010\\E",
      "shortCiteRegEx" : "Xie",
      "year" : 2010
    }, {
      "title" : "Theranostic nanomedicine",
      "author" : [ "T Lammers" ],
      "venue" : "Acc. Chem. Res",
      "citeRegEx" : "Lammers,? \\Q2011\\E",
      "shortCiteRegEx" : "Lammers",
      "year" : 2011
    }, {
      "title" : "Theranostics: past, present and future",
      "author" : [ "S. Adiga", "U.S. Adiga" ],
      "venue" : "Int. J. Pharm. Bio. Sci",
      "citeRegEx" : "Adiga and Adiga,? \\Q2014\\E",
      "shortCiteRegEx" : "Adiga and Adiga",
      "year" : 2014
    }, {
      "title" : "Optical small animal imaging in the drug discovery process",
      "author" : [ "S Dufort" ],
      "venue" : "BBA-Biomembranes",
      "citeRegEx" : "Dufort,? \\Q2010\\E",
      "shortCiteRegEx" : "Dufort",
      "year" : 2010
    }, {
      "title" : "Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity",
      "author" : [ "E. Boisselier", "D. Astruc" ],
      "venue" : null,
      "citeRegEx" : "Boisselier and Astruc,? \\Q2009\\E",
      "shortCiteRegEx" : "Boisselier and Astruc",
      "year" : 2009
    }, {
      "title" : "Handbook of Carbon, Graphite, Diamond, and Fullerenes: Properties, Processing, and Applications, Noyes Publications",
      "author" : [ "H.O. Pierson" ],
      "venue" : null,
      "citeRegEx" : "Pierson,? \\Q1993\\E",
      "shortCiteRegEx" : "Pierson",
      "year" : 1993
    }, {
      "title" : "Carbon nanotube in different shapes",
      "author" : [ "M. Zhang", "J. Li" ],
      "venue" : "Materials Today",
      "citeRegEx" : "Zhang and Li,? \\Q2009\\E",
      "shortCiteRegEx" : "Zhang and Li",
      "year" : 2009
    }, {
      "title" : "The properties and applications of nanodiamonds",
      "author" : [ "Mochalin", "V.N" ],
      "venue" : "Nat. Nanotechnol",
      "citeRegEx" : "Mochalin and V.N,? \\Q2012\\E",
      "shortCiteRegEx" : "Mochalin and V.N",
      "year" : 2012
    }, {
      "title" : "Carbon-based nanomaterials: multifunctional materials for biomedical engineering",
      "author" : [ "C Cha" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "Cha,? \\Q2013\\E",
      "shortCiteRegEx" : "Cha",
      "year" : 2013
    }, {
      "title" : "Nano-graphene in biomedicine: theranostic applications",
      "author" : [ "K Yang" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "Yang,? \\Q2013\\E",
      "shortCiteRegEx" : "Yang",
      "year" : 2013
    }, {
      "title" : "Functionalized carbon nanotubes for potential medicinal applications",
      "author" : [ "Y Zhang" ],
      "venue" : "Drug Discov. Today",
      "citeRegEx" : "Zhang,? \\Q2010\\E",
      "shortCiteRegEx" : "Zhang",
      "year" : 2010
    }, {
      "title" : "Functionalized carbon nanotubes: biomedical applications",
      "author" : [ "S Vardharajula" ],
      "venue" : "Int. J. Nanomedicine",
      "citeRegEx" : "Vardharajula,? \\Q2012\\E",
      "shortCiteRegEx" : "Vardharajula",
      "year" : 2012
    }, {
      "title" : "Diameter-controlled synthesis of carbon nanotubes",
      "author" : [ "Cheung", "C.L" ],
      "venue" : "J. Phys. Chem. B",
      "citeRegEx" : "Cheung and C.L,? \\Q2002\\E",
      "shortCiteRegEx" : "Cheung and C.L",
      "year" : 2002
    }, {
      "title" : "Controlling the diameter, growth rate, and density of vertically aligned carbon nanotubes synthesized by microwave",
      "author" : [ "Choi", "Y.C" ],
      "venue" : null,
      "citeRegEx" : "Choi and Y.C,? \\Q2000\\E",
      "shortCiteRegEx" : "Choi and Y.C",
      "year" : 2000
    }, {
      "title" : "plasma-enhanced chemical vapor deposition",
      "author" : [ "A Baliyan" ],
      "venue" : "Appl. Phys. Lett. 76,",
      "citeRegEx" : "Baliyan,? \\Q2013\\E",
      "shortCiteRegEx" : "Baliyan",
      "year" : 2013
    }, {
      "title" : "Carbon nanotubes for biomedical imaging: the recent advances",
      "author" : [ "H Gong" ],
      "venue" : "Adv. Drug Deliv. Rev",
      "citeRegEx" : "Gong,? \\Q2013\\E",
      "shortCiteRegEx" : "Gong",
      "year" : 2013
    }, {
      "title" : "and photothermal therapy",
      "author" : [ ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "J,? \\Q2015\\E",
      "shortCiteRegEx" : "J",
      "year" : 2015
    }, {
      "title" : "Carbon nanotubes as photoacoustic molecular imaging agents in living mice",
      "author" : [ "A De La Zerda" ],
      "venue" : "therapy. Adv. Funct. Mater",
      "citeRegEx" : "Zerda,? \\Q2008\\E",
      "shortCiteRegEx" : "Zerda",
      "year" : 2008
    }, {
      "title" : "The rise of graphene",
      "author" : [ "A.K. Geim", "K.S. Novoselov" ],
      "venue" : "phototherapy. ACS Appl. Mater. Interfaces",
      "citeRegEx" : "Geim and Novoselov,? \\Q2007\\E",
      "shortCiteRegEx" : "Geim and Novoselov",
      "year" : 2007
    }, {
      "title" : "photodynamic therapy of cancer cells",
      "author" : [ ],
      "venue" : "Biomaterials",
      "citeRegEx" : "Y,? \\Q2013\\E",
      "shortCiteRegEx" : "Y",
      "year" : 2013
    }, {
      "title" : "photothermal/photodynamic cancer therapy",
      "author" : [ "Robinson", "J.T" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "Robinson and J.T,? \\Q2011\\E",
      "shortCiteRegEx" : "Robinson and J.T",
      "year" : 2011
    }, {
      "title" : "Continuous, highly flexible, and transparent graphene films by chemical vapor deposition for organic",
      "author" : [ "L Gomez De Arco" ],
      "venue" : null,
      "citeRegEx" : "Arco,? \\Q2010\\E",
      "shortCiteRegEx" : "Arco",
      "year" : 2010
    }, {
      "title" : "2016) A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapy",
      "author" : [ ],
      "venue" : "photovoltaics. ACS Nano",
      "citeRegEx" : "H,? \\Q2016\\E",
      "shortCiteRegEx" : "H",
      "year" : 2016
    }, {
      "title" : "Optical and Electronic Properties of Fullerenes and Fullerene-Based Materials, Marcel Dekker 41 Partha",
      "author" : [ "Nat. Nanotechnol" ],
      "venue" : "R. and Conyers, J.L",
      "citeRegEx" : "Nanotechnol.,? \\Q2000\\E",
      "shortCiteRegEx" : "Nanotechnol.",
      "year" : 2000
    }, {
      "title" : "Separately doped upconversion-C60 nanoplatform for NIR imaging-guided photodynamic therapy of cancer cells",
      "author" : [ "X Liu" ],
      "venue" : null,
      "citeRegEx" : "Liu,? \\Q2013\\E",
      "shortCiteRegEx" : "Liu",
      "year" : 2013
    }, {
      "title" : "Facile construction of well-defined fullerene-dendrimer supramolecular nanocomposites for bioapplications",
      "author" : [ "X Li" ],
      "venue" : null,
      "citeRegEx" : "Li,? \\Q2015\\E",
      "shortCiteRegEx" : "Li",
      "year" : 2015
    }, {
      "title" : "Syntheses and properties of macromolecular fullerenes, a review",
      "author" : [ "K.E. Geckeler", "S. Samal" ],
      "venue" : "Polym. Int",
      "citeRegEx" : "Geckeler and Samal,? \\Q1999\\E",
      "shortCiteRegEx" : "Geckeler and Samal",
      "year" : 1999
    }, {
      "title" : "Luminescent carbon nanodots: Emergent nanolights",
      "author" : [ "S.N. Baker", "G.A. Baker" ],
      "venue" : "efficacy. Adv. Mater",
      "citeRegEx" : "Baker and Baker,? \\Q2010\\E",
      "shortCiteRegEx" : "Baker and Baker",
      "year" : 2010
    }, {
      "title" : "Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene",
      "author" : [ "G Jia" ],
      "venue" : null,
      "citeRegEx" : "Jia,? \\Q2005\\E",
      "shortCiteRegEx" : "Jia",
      "year" : 2005
    }, {
      "title" : "Comparative in vivo biocompatibility study of single- and multi-wall carbon nanotubes",
      "author" : [ "A Fraczek" ],
      "venue" : "Acta Biomater",
      "citeRegEx" : "Fraczek,? \\Q2008\\E",
      "shortCiteRegEx" : "Fraczek",
      "year" : 2008
    }, {
      "title" : "Toxicity issues in the application of carbon nanotubes to biological systems. Nanomed",
      "author" : [ "C.P. Firme Iii", "P.R. Bandaru" ],
      "venue" : null,
      "citeRegEx" : "Iii and Bandaru,? \\Q2010\\E",
      "shortCiteRegEx" : "Iii and Bandaru",
      "year" : 2010
    }, {
      "title" : "Carbon nanotubes as nanomedicines: from toxicology to pharmacology",
      "author" : [ "L Lacerda" ],
      "venue" : "Nanotechnol. Biol. Med",
      "citeRegEx" : "Lacerda,? \\Q2006\\E",
      "shortCiteRegEx" : "Lacerda",
      "year" : 2006
    }, {
      "title" : "A concise review of carbon nanotube’s toxicology",
      "author" : [ "Madani", "S.Y" ],
      "venue" : "Raman spectroscopy. Proc. Natl. Acad. Sci. U.S.A",
      "citeRegEx" : "Madani and S.Y,? \\Q2013\\E",
      "shortCiteRegEx" : "Madani and S.Y",
      "year" : 2013
    } ],
    "referenceMentions" : [ ],
    "year" : 2017,
    "abstractText" : null,
    "creator" : "Elsevier"
  }
}